International Companies

Merck to buy UK biotech Verona Pharma for $10bn

By Benjamin Chiou

Date: Wednesday 09 Jul 2025

(Sharecast News) - American pharma giant Merck announced on Wednesday that it is to pay $10bn for UK-based respiratory disease specialist Verona Pharma.
Verona Pharma, whose ADR shares trade on the Nasdaq, is being taken over for $107 each, up from Tuesday's closing price of $86.86, causing the share price to...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page